PCV31 COST-EFFECTIVENESS OF ACHIEVING ADDITIONAL LIPID TARGETS WHEN SUBSTITUTING FENOFIBRATE 145 MG FOR STANDARD FENOFIBRATE THERAPY
SV Sorensen; KD Frick; R Burge; RJ Simko
- 作者SV Sorensen; KD Frick; R Burge; RJ Simko
- 卷第10卷
- 期第3期
- 文件大小69.24KB
- 发表时间2007
- DOI10.1016/s1098-3015(10)68675-5